E Daily Stock Analysis: GlaxoSmithKline
GSK Gains?
Adding the $1.97 annual anticipated dividend to my $7.02 optimistic estimate of GlaxoSmithKline PLC's price upside shows an $8.99 potential gross gain, per share, to be reduced by any costs to trade the shares.
Put little under $1,000.00 today in GlaxoSmithKline PLC at $37.98 and we would buy 26 shares GSK stock.
A $10 broker fee (if any) paid half at purchase and half at sale could cost us about $0.38 per share.
Subtract that maybe $0.38 brokerage cost from my estimated $8.99 gross gain per share results in a net gain of $8.61 X 26 shares = $223.86 or a 22.4% net gain on a $987.48 investment.
So it goes that GlaxoSmithKline PLC shows a possible 22.4% net gain including a 5.19% dividend yield. It could be more, it could be less.
All of the estimates above are speculation based on the past history of GlaxoSmithKline PLC. Only time and money invested in this stock will determine its worth.
Disclaimer: This article is for informational and educational purposes only and should not be construed to constitute investment advice. Nothing contained herein shall constitute a solicitation, ...
more
Comments
